Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 3, 2002

View Archived Issues

Medtronic acquires Endonetics

Ibuprofen blocks beneficial effects of aspirin in heart attack prevention

Osteopontin may offer a potential target in blocking development of progressive multiple sclerosis

Defining the mechanism by which niacin mediates its antiatherogenic properties

Meta-analysis shows efficacy of terazosin is independent of prostate size

Tamsulosin may provide effective treatment for reboxetine-associated urinary hesitancy

Roche claims new antiinflammatory and analgesic compounds

Avax Technologies buys back interest in Australian joint venture

New compounds for the treatment of asthma in the Roche pipeline

Warner-Lambert describes a new method for inhibiting amyloid protein aggregation

Nippon Shinyaku patents novel nociceptin receptor agonists

Eisai reports new acetylcholinesterase inhibitors

Amino acid derivatives and their use as medicines described by SCRAS researchers

Antiviral drugs containing nitrogenous compounds disclosed by Kureha

Merck/Schering-Plough seeks FDA approval for Zetia in elevated cholesterol

Ilex buys out Millennium's equity interests in their Campath joint venture

Therion Biologics' cancer vaccine enters phase I trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...